Retail Trade Sugi Holdings Co., Ltd. Business Summary
Sugi Holdings Co., Ltd. engages in the management of its group companies which provides the management of the drug stores and dispensing business. The company provides the sale of medicines, health foods, cosmetics, daily necessities and prescription preparations, as well as the operation of local healthcare compliant drug store that tackles home healthcare in cooperation with regional medical personnel. It also operates visiting nursing stations that closely cooperate with regional medical institutions and social welfare operators, through the provision of visiting nursing services and in-home nursing care support services. The company was founded in December 1976 and is headquartered in Obu, Japan.
Financial Highlights
Feb 2023
JPY USD Revenue 667,647M 4,975.93M Gross Profit 202,524M 1,509.40M Operating income 31,659M 235.95M Income before tax 28,184M 210.05M Net income 19,007M 141.65M EBITDA 44,021M 328.08M Diluted EPS 311.44 2.32 Dividends Per Share 80 0.59 Total Assets 353,249M 2,593.31M Total liabilities 136,709M 1,003.62M Total equity 216,538M 1,589.67M Operating cash flow 38,279M 285.29M Currency in JPY Currency in USD
Historical Data Feb 2019 Feb 2020 Feb 2021 Feb 2022 Feb 2023 Revenue
488,464M
541,964M
602,850M
625,477M
667,647M
Gross Profit
142,300M
162,182M
181,631M
191,490M
202,524M
Operating income
25,817M
29,762M
34,041M
32,137M
31,659M
Income before tax
26,053M
29,926M
31,521M
27,456M
28,184M
Net income
17,940M
20,782M
21,120M
19,389M
19,007M
EBITDA
33,206M
38,174M
43,981M
43,405M
44,021M
Diluted EPS
287.73
336.20
341.67
313.66
311.44
Dividends Per Share
70
80
80
80
80
Total Assets
266,529M
314,905M
347,977M
336,380M
353,249M
Total liabilities
99,964M
132,153M
147,346M
122,488M
136,709M
Total equity
166,563M
182,750M
200,629M
213,890M
216,538M
Operating cash flow
22,894M
45,353M
34,027M
7,174M
38,279M
Feb 2019 Feb 2020 Feb 2021 Feb 2022 Feb 2023 Revenue
4,421.30M
4,971.69M
5,689.35M
5,609.66M
4,975.93M
Gross Profit
1,288.02M
1,487.77M
1,714.13M
1,717.40M
1,509.40M
Operating income
233.68M
273.02M
321.25M
288.22M
235.95M
Income before tax
235.81M
274.52M
297.47M
246.24M
210.05M
Net income
162.38M
190.64M
199.31M
173.89M
141.65M
EBITDA
300.56M
350.18M
415.06M
389.28M
328.08M
Diluted EPS
2.60
3.08
3.22
2.81
2.32
Dividends Per Share
0.63
0.73
0.75
0.71
0.59
Total Assets
2,394.25M
2,919.43M
3,266.16M
2,920.59M
2,593.31M
Total liabilities
897.98M
1,225.17M
1,383.01M
1,063.49M
1,003.62M
Total equity
1,496.25M
1,694.24M
1,883.13M
1,857.08M
1,589.67M
Operating cash flow
207.22M
416.04M
321.12M
64.34M
285.29M
Valuation Measures
Feb 2023
PER 18.30 ROA 5.51% ROE 8.83% Operating margin 4.74% Profit margin 2.84%
Management
President & Representative Director:
Katsunori Sugiura
Manager-Corporate Planning Office:
Makoto Kasai Shareholders
SUGIURA FAMILY (35.6%)
Baillie Gifford & Co. (6.1%)
Orbis Investment Management Ltd. (5.1%)
Sugi Asset Godo Kaisha (4.7%)
Sugi Holdings Co., Ltd. (4.7%)
MFS International (UK) Ltd. (2.5%)
Nomura Asset Management Co., Ltd. (2.2%)
TSURUHA Holdings, Inc. (2.0%)
The Vanguard Group, Inc. (1.8%)
Norges Bank Investment Management (1.3%)
Related Companies
Sugi Holdings Restricted Stock Compensation Plan
Watanabe Boeki KK
Sugi Medical Co. Ltd.
Sugi Pharmacy Co., Ltd.
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Last Updated on 26 Sep, 2023
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.
Celebrate our next chapter Find out more